Literature DB >> 28942121

Ex vivo construction of human primary 3D-networked osteocytes.

Qiaoling Sun1, Saba Choudhary2, Ciaran Mannion3, Yair Kissin4, Jenny Zilberberg5, Woo Y Lee6.   

Abstract

A human bone tissue model was developed by constructing ex vivo the 3D network of osteocytes via the biomimetic assembly of primary human osteoblastic cells with 20-25μm microbeads and subsequent microfluidic perfusion culture. The biomimetic assembly: (1) enabled 3D-constructed cells to form cellular network via processes with an average cell-to-cell distance of 20-25μm, and (2) inhibited cell proliferation within the interstitial confine between the microbeads while the confined cells produced extracellular matrix (ECM) to form a mechanically integrated structure. The mature osteocytic expressions of SOST and FGF23 genes became significantly higher, especially for SOST by 250 folds during 3D culture. The results validate that the bone tissue model: (1) consists of 3D cellular network of primary human osteocytes, (2) mitigates the osteoblastic differentiation and proliferation of primary osteoblast-like cells encountered in 2D culture, and (3) therefore reproduces ex vivo the phenotype of human 3D-networked osteocytes. The 3D tissue construction approach is expected to provide a clinically relevant and high-throughput means for evaluating drugs and treatments that target bone diseases with in vitro convenience.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  3D culture; FGF23; Human bone tissue model; Human primary osteoblasts; Human primary osteocytes; Microfluidic; SOST; Sclerostin

Mesh:

Substances:

Year:  2017        PMID: 28942121      PMCID: PMC5690542          DOI: 10.1016/j.bone.2017.09.012

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  44 in total

1.  RANKL and OPG activity is regulated by injury size in networks of osteocyte-like cells.

Authors:  Lauren E Mulcahy; David Taylor; T Clive Lee; Garry P Duffy
Journal:  Bone       Date:  2010-09-18       Impact factor: 4.398

2.  Isolation of osteocytes from human trabecular bone.

Authors:  Matthew Prideaux; Christine Schutz; Asiri R Wijenayaka; David M Findlay; David G Campbell; Lucian B Solomon; Gerald J Atkins
Journal:  Bone       Date:  2016-04-22       Impact factor: 4.398

3.  Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: reduction post-bortezomib monotherapy.

Authors:  Evangelos Terpos; Dimitrios Christoulas; Eirini Katodritou; Cornelia Bratengeier; Maria Gkotzamanidou; Eurydiki Michalis; Sosana Delimpasi; Anastasia Pouli; John Meletis; Efstathios Kastritis; Konstantinos Zervas; Meletios A Dimopoulos
Journal:  Int J Cancer       Date:  2011-12-21       Impact factor: 7.396

4.  Sclerostin is overexpressed by plasma cells from multiple myeloma patients.

Authors:  Giacomina Brunetti; Angela Oranger; Giorgio Mori; Giorgina Specchia; Erminia Rinaldi; Paola Curci; Alberta Zallone; Rita Rizzi; Maria Grano; Silvia Colucci
Journal:  Ann N Y Acad Sci       Date:  2011-11       Impact factor: 5.691

5.  Bone remodelling at a glance.

Authors:  Julie C Crockett; Michael J Rogers; Fraser P Coxon; Lynne J Hocking; Miep H Helfrich
Journal:  J Cell Sci       Date:  2011-04-01       Impact factor: 5.285

6.  Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastases.

Authors:  Sandy R Larson; Xiaotun Zhang; Ruth Dumpit; Ilsa Coleman; Bryce Lakely; Martine Roudier; Celestia S Higano; Lawrence D True; Paul H Lange; Bruce Montgomery; Eva Corey; Peter S Nelson; Robert L Vessella; Colm Morrissey
Journal:  Prostate       Date:  2013-01-17       Impact factor: 4.104

7.  Microbeads-Guided Reconstruction of 3D Osteocyte Network during Microfluidic Perfusion Culture.

Authors:  Yexin Gu; Wenting Zhang; Qiaoling Sun; Yi Hao; Jenny Zilberberg; Woo Y Lee
Journal:  J Mater Chem B       Date:  2015-03-25       Impact factor: 6.331

8.  Feasibility assessment of a chemoresponse assay to predict pathologic response in neoadjuvant chemotherapy for breast cancer patients.

Authors:  Zhibao Mi; Frankie A Holmes; Beth Hellerstedt; John Pippen; Rufus Collea; Amanda Backner; Jason E Bush; Holly H Gallion; Alan Wells; Joyce A O'Shaughnessy
Journal:  Anticancer Res       Date:  2008 May-Jun       Impact factor: 2.480

9.  A new method to investigate how mechanical loading of osteocytes controls osteoblasts.

Authors:  Marisol Vazquez; Bronwen A J Evans; Daniela Riccardi; Sam L Evans; Jim R Ralphs; Christopher Mark Dillingham; Deborah J Mason
Journal:  Front Endocrinol (Lausanne)       Date:  2014-12-09       Impact factor: 5.555

10.  Can bone tissue engineering contribute to therapy concepts after resection of musculoskeletal sarcoma?

Authors:  Boris Michael Holzapfel; Mohit Prashant Chhaya; Ferry Petrus Wilhelmus Melchels; Nina Pauline Holzapfel; Peter Michael Prodinger; Ruediger von Eisenhart-Rothe; Martijn van Griensven; Jan-Thorsten Schantz; Maximilian Rudert; Dietmar Werner Hutmacher
Journal:  Sarcoma       Date:  2013-01-14
View more
  11 in total

Review 1.  Investigating Osteocytic Perilacunar/Canalicular Remodeling.

Authors:  Cristal S Yee; Charles A Schurman; Carter R White; Tamara Alliston
Journal:  Curr Osteoporos Rep       Date:  2019-08       Impact factor: 5.096

2.  Hypoxic Three-Dimensional Cellular Network Construction Replicates Ex Vivo the Phenotype of Primary Human Osteocytes.

Authors:  Saba Choudhary; Qiaoling Sun; Ciaran Mannion; Yair Kissin; Jenny Zilberberg; Woo Y Lee
Journal:  Tissue Eng Part A       Date:  2017-08-02       Impact factor: 3.845

3.  Ex vivo replication of phenotypic functions of osteocytes through biomimetic 3D bone tissue construction.

Authors:  Qiaoling Sun; Saba Choudhary; Ciaran Mannion; Yair Kissin; Jenny Zilberberg; Woo Y Lee
Journal:  Bone       Date:  2017-10-21       Impact factor: 4.398

4.  Natural killer cells activity against multiple myeloma cells is modulated by osteoblast-induced IL-6 and IL-10 production.

Authors:  Christopher Uhl; Themba Nyirenda; David S Siegel; Woo Y Lee; Jenny Zilberberg
Journal:  Heliyon       Date:  2022-03-24

Review 5.  Osteon: Structure, Turnover, and Regeneration.

Authors:  Bei Chang; Xiaohua Liu
Journal:  Tissue Eng Part B Rev       Date:  2021-03-08       Impact factor: 7.376

6.  Human ex vivo 3D bone model recapitulates osteocyte response to metastatic prostate cancer.

Authors:  Saba Choudhary; Poornema Ramasundaram; Eugenia Dziopa; Ciaran Mannion; Yair Kissin; Lucas Tricoli; Christopher Albanese; Woo Lee; Jenny Zilberberg
Journal:  Sci Rep       Date:  2018-12-19       Impact factor: 4.379

Review 7.  Cell Sources for Human In vitro Bone Models.

Authors:  Sana Ansari; Keita Ito; Sandra Hofmann
Journal:  Curr Osteoporos Rep       Date:  2021-01-15       Impact factor: 5.096

8.  A Three-Dimensional Mechanical Loading Model of Human Osteocytes in Their Native Matrix.

Authors:  Chen Zhang; Elisabet Farré-Guasch; Jianfeng Jin; Huib W van Essen; Jenneke Klein-Nulend; Nathalie Bravenboer
Journal:  Calcif Tissue Int       Date:  2021-10-13       Impact factor: 4.333

Review 9.  Organ-on-a-chip platforms for accelerating the evaluation of nanomedicine.

Authors:  Xi Chen; Yu Shrike Zhang; Xinping Zhang; Changsheng Liu
Journal:  Bioact Mater       Date:  2020-10-12

10.  Triple Culture of Primary Human Osteoblasts, Osteoclasts and Osteocytes as an In Vitro Bone Model.

Authors:  Anne Bernhardt; Jasmin Skottke; Max von Witzleben; Michael Gelinsky
Journal:  Int J Mol Sci       Date:  2021-07-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.